{"result": "(\"entity\"<|>LITIASIS RENAL<|>EVENT<|>Litiasis renal is a urological condition affecting 5-15% of the population, causing significant morbidity and healthcare costs.)\n##\n(\"entity\"<|>HIPERURICEMIA<|>EVENT<|>Hiperuricemia is a metabolic condition characterized by elevated levels of uric acid in the blood, often associated with kidney stones.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic disease that is frequently related to nephrolithiasis and other metabolic disorders.)\n##\n(\"entity\"<|>OBESIDAD<|>EVENT<|>Obesidad refers to obesity, a condition that increases the risk of developing kidney stones and is linked to metabolic syndrome.)\n##\n(\"entity\"<|>SÍNDROME METABÓLICO<|>EVENT<|>Sindrome metabólico is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes, often associated with kidney stone formation.)\n##\n(\"entity\"<|>ENFERMEDAD CARDIOVASCULAR<|>EVENT<|>Enfermedad cardiovascular encompasses various heart conditions that can be related to metabolic disorders like nephrolithiasis.)\n##\n(\"entity\"<|>TABLA 4<|>ORGANIZATION<|>Tabla 4 summarizes nutritional recommendations for patients with hyperuricemia and/or uric acid lithiasis.)\n##\n(\"entity\"<|>BOIX GC<|>PERSON<|>Boix GC is an author of a study on kidney stones published in Rev Clín Med Fam.)\n##\n(\"entity\"<|>LÓPEZ-TORRES HJ<|>PERSON<|>López-Torres HJ is a co-author of a study on kidney stones published in Rev Clín Med Fam.)\n##\n(\"entity\"<|>ÁLVAREZ DL<|>PERSON<|>Álvarez DL is a co-author of a study on kidney stones published in Rev Clín Med Fam.)\n##\n(\"entity\"<|>VÁZQUEZ CM<|>PERSON<|>Vázquez CM is a co-author of a study on kidney stones published in Rev Clín Med Fam.)\n##\n(\"entity\"<|>ROMERO HE<|>PERSON<|>Romero HE is a co-author of a study on kidney stones published in Rev Clín Med Fam.)\n##\n(\"entity\"<|>JIMÉNEZ LM<|>PERSON<|>Jiménez LM is a co-author of a study on kidney stones published in Rev Clín Med Fam.)\n##\n(\"entity\"<|>SAIGAL CS<|>PERSON<|>Saigal CS is an author of a study on the costs of nephrolithiasis published in Kidney Int.)\n##\n(\"entity\"<|>JOYCE G<|>PERSON<|>Joyce G is a co-author of a study on the costs of nephrolithiasis published in Kidney Int.)\n##\n(\"entity\"<|>TIMILSINA AR<|>PERSON<|>Timilsina AR is a co-author of a study on the costs of nephrolithiasis published in Kidney Int.)\n##\n(\"entity\"<|>ROMERO V<|>PERSON<|>Romero V is an author of a study on kidney stones published in Rev Urol.)\n##\n(\"entity\"<|>AKPINAR H<|>PERSON<|>Akpinar H is a co-author of a study on kidney stones published in Rev Urol.)\n##\n(\"entity\"<|>ASSIMOS DG<|>PERSON<|>Assimos DG is a co-author of a study on kidney stones published in Rev Urol.)\n##\n(\"relationship\"<|>LITIASIS RENAL<|>HIPERURICEMIA<|>Litiasis renal is often caused by hyperuricemia, which leads to the formation of kidney stones.<|>8)\n##\n(\"relationship\"<|>LITIASIS RENAL<|>DIABETES<|>Diabetes is frequently associated with the development of kidney stones.<|>6)\n##\n(\"relationship\"<|>LITIASIS RENAL<|>OBESIDAD<|>Obesity is a risk factor for the development of kidney stones.<|>6)\n##\n(\"relationship\"<|>LITIASIS RENAL<|>SÍNDROME METABÓLICO<|>Metabolic syndrome increases the risk of kidney stone formation.<|>6)\n##\n(\"relationship\"<|>LITIASIS RENAL<|>ENFERMEDAD CARDIOVASCULAR<|>Cardiovascular disease is linked to metabolic disorders that can lead to kidney stones.<|>6)\n##\n(\"relationship\"<|>HIPERURICEMIA<|>OBESIDAD<|>Obesity is a contributing factor to hyperuricemia and its related conditions.<|>5)\n##\n(\"relationship\"<|>HIPERURICEMIA<|>SÍNDROME METABÓLICO<|>Hyperuricemia is often associated with metabolic syndrome.<|>5)\n##\n(\"relationship\"<|>TABLA 4<|>LITIASIS RENAL<|>Tabla 4 provides dietary recommendations aimed at preventing kidney stones.<|>7)\n##\n(\"relationship\"<|>BOIX GC<|>TABLA 4<|>Boix GC contributed to the study that includes the recommendations in Tabla 4.<|>4)\n##\n(\"relationship\"<|>LÓPEZ-TORRES HJ<|>TABLA 4<|>López-Torres HJ contributed to the study that includes the recommendations in Tabla 4.<|>4)\n##\n(\"relationship\"<|>ÁLVAREZ DL<|>TABLA 4<|>Álvarez DL contributed to the study that includes the recommendations in Tabla 4.<|>4)\n##\n(\"relationship\"<|>VÁZQUEZ CM<|>TABLA 4<|>Vázquez CM contributed to the study that includes the recommendations in Tabla 4.<|>4)\n##\n(\"relationship\"<|>ROMERO HE<|>TABLA 4<|>Romero HE contributed to the study that includes the recommendations in Tabla 4.<|>4)\n##\n(\"relationship\"<|>JIMÉNEZ LM<|>TABLA 4<|>Jiménez LM contributed to the study that includes the recommendations in Tabla 4.<|>4)\n##\n(\"relationship\"<|>SAIGAL CS<|>HIPERURICEMIA<|>Saigal CS's study discusses the costs associated with conditions like hyperuricemia.<|>5)\n##\n(\"relationship\"<|>JOYCE G<|>HIPERURICEMIA<|>Joyce G's study discusses the costs associated with conditions like hyperuricemia.<|>5)\n##\n(\"relationship\"<|>TIMILSINA AR<|>HIPERURICEMIA<|>Timilsina AR's study discusses the costs associated with conditions like hyperuricemia.<|>5)\n##\n(\"relationship\"<|>ROMERO V<|>LITIASIS RENAL<|>Romero V's study provides insights into kidney stones and their risk factors.<|>5)\n##\n(\"relationship\"<|>AKPINAR H<|>LITIASIS RENAL<|>Akpinar H's study provides insights into kidney stones and their risk factors.<|>5)\n##\n(\"relationship\"<|>ASSIMOS DG<|>LITIASIS RENAL<|>Assimos DG's study provides insights into kidney stones and their risk factors.<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: recomendación de pérdida de peso también es extensible a los sujetos obesos con litiasis úrica.\n\nLas principales recomendaciones nutricionales y de estilo de vida en pacientes con hiperuricemia y/o nefrolitiasis úrica quedan reflejadas en la tabla 4.\n\n## 7. Resumen\n\nLa litiasis renal representa la tercera patología urológica más frecuente, afectando al 5-15% de la población que condiciona una importante morbilidad y elevados costes sanitarios. Hoy en día, la nefrolitiasis está considerada una patología sistémica y crónica frecuentemente relacionada con enfermedades como la diabetes, la obesidad, el síndrome metabólico y la enfermedad cardiovascular.\n\nPara la formación del cálculo renal se requiere necesariamente que la concentración de la sal formadora exceda su solubilidad en la orina, es decir se encuentre en estado de sobresaturación. Diversos factores dietéticos y metabólicos juegan un papel fundamental en la etiopatogenia de esta enfermedad, probablemente al modular la composición urinaria. Las alteraciones metabólicas más frecuentemente asociadas a la nefrolitiasis renal son la hipercalciuria, la hiperoxaluria, la hipocitraturia y las alteraciones del pH urinario. En todos los pacientes que han presentado un primer episodio de litiasis renal única se recomienda realizar un cribado básico inicial para conocer la etiología y características del cálculo y en aquellos sujetos con alto riesgo de recurrencia, este cribado debe ser ampliado a una valoración metabólica más completa.\n\nEl tratamiento dietético de la nefrolitiasis tiene un carácter profiláctico cuyo objetivo está basado en la reducción de los factores de riesgo litogénicos y en la prevención de las recurrencias. Las principales modificaciones dietéticas están centradas en la adopción de una dieta equilibrada basada en un alto consumo de verduras y frutas, que contenga una adecuada cantidad de calcio (1-1,2 g/día), limitando la ingesta de proteínas animales (0,8 g/día), de sodio (< 3,5 g/día) y de oxalato y donde la ingesta hídrica sea superior a los 2,5 litros de líquidos al día.\n\nEl ácido úrico es el producto final del metabolismo de las purinas, donde el 75% del ácido úrico proviene de la degradación de las purinas endógenas y el resto de las purinas de la dieta. Tan solo el 10% de las hiperuricemias son causadas por un aumento de la producción de ácido úrico. Alrededor del 20-25% de los pacientes con hiperuricemia y gota presentan litiasis renal. La hiperuricemia no solo está vinculada con la formación de cálculos de ácido úrico, sino también con el desarrollo de litiasis cálcica. La cristalización del ácido úrico ocurre fundamentalmente como consecuencia de una disminución del pH urinario.\n\nAlgunos factores de riesgo dietéticos y de estilo de vida implicados en el desarrollo de la hiperuricemia son las carnes rojas, los pescados, el abuso de alcohol, en especial cerveza y licores, las bebidas edulcoradas, los alimentos con alto contenido en fructosa y la obesidad. Hoy en día se considera que las dietas muy bajas en purinas no son el elemento fundamental en el tratamiento de la hiperuricemia y la litiasis úrica, ya que son difíciles de seguir a largo plazo y además algunos alimentos con alto contenido en purinas como las legumbres y verduras no se han relacionado con la aparición de hiperuricemia.\n\n## 8. Bibliografía\n\n1. Boix GC, López-Torres HJ, Álvarez DL, Vázquez CM, Romero HE, Jiménez LM, et al. Litiasis Renal. Rev Clín Med Fam. 2007; 2: 32-38.\n2. Saigal CS, Joyce G, Timilsina AR; Urologic Diseases in America Project. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int 2005; 68:1808-14.\n3. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010; 12:86-96.\n\n| Tabla 4. Resumen de las recomendaciones nutricionales en la hiperuricemia y/o litiasis úrica. |\n|---|\n| · Disminución de peso, si existe sobrepeso u obesidad |\n| · Suprimir el consumo de bebidas alcohólicas como la cerveza y los licores |\n| · Evitar la ingesta de refrescos y otras bebidas edulcoradas con contenido elevado de fructosa |\n| · Reducir al máximo el consumo de carnes rojas y vísceras |\n| · Permitir la ingesta de p\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}